Growth in vitamin D therapy market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market.
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases). The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32540026
The oral route of administration dominated the vitamin D therapy market in 2018
By route of administration, the vitamin D therapy market is segmented into oral and parenteral routes of administration. In 2018, the oral route accounted for the largest share of the market. The large share of this segment can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, its economy (as compared to parenteral and topical routes), and higher preference for the oral route.
Osteoporosis held the largest share of the applications market in 2018
Based on applications, the vitamin D therapy market is segmented into osteoporosis, rickets, skin diseases, muscle weakness, autoimmune disorders, and other applications. In 2018, the osteoporosis segment accounted for the largest share of the vitamin D therapy market. The large share of this segment can be attributed to the increasing incidence of falls and fractures in senior adults due to the elevated level of parathyroid hormones and the poor absorption of calcium from their diets.
The Asia Pacific commanded the largest share of the vitamin D therapy market in 2018
The Asia Pacific dominated the vitamin D therapy market. The large share of this regional segment can be attributed to the increasing awareness about vitamin D deficiency, supportive government policies and programs for the implementation of vitamin D deficiency treatment plans in the region, heavy air pollution, sedentary lifestyles, increasing incidence of vitamin D deficiency, decreasing sun exposure, and rising malnutrition levels.
Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32540026
Key Players
Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population.
On the other hand, the fortification of foods is likely to challenge the growth of this market.The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period.Oral route of administration expected to fuel the growth of the vitamin D therapy market over the forecast period.By route of administration, the market is segmented into oral and parenteral routes of administration.
This can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route.Increasing use of vitamin D in osteoporosis to drive market growth during the forecast period.Based on application, the market is segmented into osteoporosis, rickets, skin diseases, muscle weakness, autoimmune disorders, and other applications.
The osteoporosis segment is expected to register the highest growth during the forecast period.
This growth can be attributed to the increasing incidence of falls and fractures in senior adults due to the elevated levels of parathyroid hormones and the poor absorption of calcium from their diets.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32540026Key Questions Addressed in the Report:What are the growth opportunities in the vitamin D therapy market across major regions?Emerging countries have immense opportunities for the growth and adoption of vitamin D. Will this scenario continue during the next five years?Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?What are the various vitamin D companies and their respective market shares in the overall market?What are the new trends and advancements in the vitamin D therapy market?The Asia Pacific to grow at the highest rate during the forecast period (2018–2023).The vitamin D therapy market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).
The Asia Pacific dominated the market in 2018 and is expected to register the highest CAGR during the forecast period.
